Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments.
Level 5 - mechanism / opinion, no new human data
Narrative review of pharmacological mechanisms and treatments without systematic search methodology or meta-analysis.
PubMed 39456160 · doi:10.3390/biom14101227
What was done
This narrative literature review evaluated established pharmacological options (bile acid sequestrants, antihistamines, opioid antagonists, sertraline, and rifampicin) alongside emerging therapeutic classes (monoclonal antibodies, PPAR agonists, and bile-acid-based agents) for the management of cholestatic pruritus. The authors summarized mechanisms of action, clinical limitations, and adverse effect profiles.
What was found
The abstract reports no quantitative data or specific numerical outcomes. It notes that standard treatments (such as anion exchange resins and rifampicin) achieve partial symptom relief but are limited by side effects, while novel agents targeting bile recirculation and pruritus signaling pathways represent prospective alternative strategies.
Why it matters
Cholestatic itch can be severe and refractory, significantly impairing patient quality of life. Synthesizing the mechanisms and limitations of current and pipeline therapies helps contextualize unmet clinical needs.
Limits
The paper is a non-systematic narrative review without defined search strings, inclusion criteria, quality appraisal of cited literature, or quantitative synthesis. No study-level or patient-level data are presented in the abstract.
Cited by
- supports Bile backing up into the skin causes itching and tissue inflammation.